Extrawell Pharmaceutical Holdings Limited announced earnings results for the full year ended March 31, 2021. For the full year, the company announced sales was HKD 78.802 million compared to HKD 77.584 million a year ago. Net loss was HKD 121.098 million compared to net income of HKD 83.280 million a year ago. Basic loss per share from continuing operations was HKD 0.0507 compared to basic earnings per share from continuing operations of HKD 0.0348 a year ago. Diluted loss per share from continuing operations was HKD 0.0507 compared to diluted earnings per share from continuing operations of HKD 0.0281 a year ago.